Skip to content
2000
Volume 6, Issue 1
  • ISSN: 2212-3962
  • E-ISSN: 1574-8901

Abstract

Recent advances in technology and novel pharmaceutical research findings have added new grounds in the fields of medical treatment and quality of life of patients diagnosed with pulmonary arterial hypertension (PAH). Collective assessment of new data is mandatory and useful for specialist medical doctors. This review aims to present the latest therapeutic developments of the last two years (2009-2010) in PAH. Moreover, recent patents (of the year 2010) regarding therapeutic novelties in PAH that expand treatment modalities, are hereby presented.

Loading

Article metrics loading...

/content/journals/prc/10.2174/157489011794578491
2011-01-01
2025-10-14
Loading full text...

Full text loading...

/content/journals/prc/10.2174/157489011794578491
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test